Stock Price Quote

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE203.90-2.15 (-1.04 %)
PREV CLOSE ( ) 206.05
OPEN PRICE ( ) 206.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 86651
TODAY'S LOW / HIGH ( )200.40 213.30
52 WK LOW / HIGH ( )168 659.7
NSE203.85-2 (-0.97 %)
PREV CLOSE( ) 205.85
OPEN PRICE ( ) 206.10
BID PRICE (QTY) 203.85 (1425)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2367599
TODAY'S LOW / HIGH( ) 200.50 213.70
52 WK LOW / HIGH ( )161.65 659.3
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-11 1977
Management Info
Glenn Saldanha - Chairman Glenn Saldanha - Managing Director
Registered Office

Address B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,
Mumbai,
Maharashtra-400026

Phone

Email webmaster@glenmarkpharma.com

Website www.glenmarkpharma.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

26Mar Glenmark surges on the BSE
Glenmark Pharmaceuticals is currently trading at Rs. 209.50, up by 17.65..
24Mar Glenmark, Yes Bank and Mangalam Drugs
Glenmark Pharmaceuticals has entered into an agreement with Hindustan Un..
24Mar Glenmark inks pact to divest VWash bra
Glenmark Pharmaceuticals has entered into an agreement with Hindustan Un..
24Mar Glenmark surges on inking pact to dive
Glenmark Pharmaceuticals is currently trading at Rs. 191.85, up by 3.85..
23Mar Glenmark, Godrej Properties and Info E
Glenmark Pharmaceuticals’ subsidiary -- Glenmark Pharmaceuticals Inc., U..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit3455.2616221.12
Gross Profit 4106.4 18181.84
Operating Profit 5080.3818030.92
Net Sales 18162.8563048.67

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  6483.75 (3.87%)
M.Cap ( in Cr)14932.48
Abbott India (BSE)
peergroup  15639.50 (1.19%)
M.Cap ( in Cr)33232.85
Hester Biosciences (BSE)
peergroup  951.70 (2.88%)
M.Cap ( in Cr)809.60
Procter&Gamble Healt (BSE)
peergroup  3669.75 (0.69%)
M.Cap ( in Cr)6091.56
NGL Fine-Chem (BSE)
peergroup  274.45 (8.33%)
M.Cap ( in Cr)169.56

Shareholding Pattern

PROMOTERS 46.59%
MUTUAL FUNDS/UTI 4.07%
FI/BANKS/INSURANCE 2.97%
NON-INSTITUTION 16.21%
GOVERNMENT 0%
FII 0%

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 1977. Its today's share price is 206.05. Its current market capitalisation stands at Rs 5753.41 Cr. In the latest quarter, company has reported Gross Sales of Rs. 70091.65 Cr and Total Income of Rs.74847.79 Cr. The company's management includes Saira Ramasastry, D R Mehta, Milind Sarwate, Julio F Ribeiro, B E Saldanha, Sridhar Gorthi, Bernard Munos, Brian W Tempest, Rajesh V Desai, VS Mani, Cherylann Pinto, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X